Search results
NanoViricides completes Phase 1 trial for respiratory viral infection candidate
Proactive Investors· 1 week agoIt has been found to be active against coronavirus infection, RSV infection, and smallpox and...
Supreme Court to hear Trump immunity claim in election interference case
CNBC· 2 weeks agoU.S. President Donald Trump delivers an update on the so-called Operation Warp Speed program, the...
‘Strategic shift’ as US overtakes mainland China as Taiwan’s top export market
South China Morning Post· 2 weeks agoThe US Department of Commerce’s Bureau of Industry and Security updated its export controls in 2022...
NanoViricides Reports that the Phase I NV-387 Clinical Trial is Completed Successfully and Data Lock...
Digital Journal· 1 week agoI Clinical Trial of NV-387 is completed successfully and data lock is expected soon. The Phase 1 clinical trial, protocol number KM-NVCoV2-001, which received approval from the regulatory agency ...